Billings Clinic
Especially For:

Clinical Trials

Title   SWOG S0800: Breast Cancer Neoadjuvant Inflammatory and Locally Advanced Her-2 Neu Negative
Description   A Randomized Phase II Trial of Weekly Nanoparticle Albumin Bound Paclitaxel with or without Bevacizumab, Either Cyclophoaphamide plus Pegfilgrastim as Neoadjuvant Therapy for Inflammatory and Locally Advanced Her-2 NEU Negative Breast Cancer
IRB Number   SWOG 0800
Category   Breast Cancer
Inclusion/Notes   Must be HER-2 Negative
Neoadjuvant Treatment
Bevacizumab Provided
Status   Active
Start Date   11/13/2009
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan Koch, RN
Contact Email   jkoch@billingsclinic.org
Phone   (406) 435-7481
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.